Article Figures & Tables
Tables
- Table 1:
Summary of recommendations for screening for lung cancer from Canada and elsewhere
Organization Recommendation Canadian Task Force on Preventive Health Care (current) Screen asymptomatic adults aged 55 to 74 years with at least a 30 pack-year smoking history who smoke or quit smoking less than 15 years ago for lung cancer with low-dose CT every year for 3 consecutive years Canadian Task Force on Preventive Health Care (2003)5 Do not screen asymptomatic adults for lung cancer with chest radiography; insufficient evidence for using low-dose CT as a screening test for asymptomatic adults US Preventive Services Task Force (2013)4 Screen asymptomatic adults aged 55 to 80 years with a minimum 30 pack-year smoking history who smoke or quit smoking within the last 15 years for lung cancer with low-dose CT annually Cancer Care Ontario (2013)26 Screen high-risk populations (i.e., adults 55–74 yr of age with a minimum smoking history of 30 pack-years or more who currently smoke or quit smoking within the past 15 yr and are free of disease at the time of screening) for lung cancer with low-dose CT for 3 years followed by biennial screening American Cancer Society (2013)27 Screen adults aged 55 to 74 years with a 30 pack-year or more smoking history who smoke or quit smoking within the previous 15 years and are in relatively good health for lung cancer with low-dose CT annually American College of Chest Physicians (2013)28 Screen adults aged 55 to 74 years with a 30 pack-year or more smoking history who smoke or quit smoking within the previous 15 years for lung cancer with low-dose CT annually American Lung Association (2012, updated 2015)29 Screen adults aged 55 to 74 years with a smoking history of at least 30 pack-years and no history of lung cancer who smoke or quit smoking with the last 15 years for lung cancer using low-dose CT annually American Association for Thoracic Surgery (2012)30 Screen adults aged 55 to 79 years with a 30 pack-year or more smoking history; adults with a previous diagnosis of lung cancer who have completed 4 years of surveillance without recurrence, and who can tolerate lung cancer treatment following screening to detect second primary lung cancer until the age of 79 years; and adults aged 50 to 79 years with a 20 pack-year smoking history and an additional comorbidity that produces a cumulative risk of lung cancer of 5% or more in 5 years for lung cancer with low-dose CT annually National Comprehensive Cancer Network (2015)31 Screen adults aged 55 to 74 years with a 30 pack-year or more smoking history who quit smoking less than 15 years ago, and adults aged 50 years or older with a 20 pack-year or more smoking history and 1 additional risk factor (other than exposure to second-hand smoke) for lung cancer with low-dose CT annually American Academy of Family Physicians (2013)32 Insufficient evidence to recommend for or against screening for lung cancer with low-dose CT Note: CT = computed tomography.
In this issue
Article extras
Article tools
Jump to section
Related Articles
Cited By...
- International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study
- Trop tot ou trop tard?: Choisir le bon intervalle pour les tests de depistage
- Too soon or too late?: Choosing the right screening test intervals
- Depistage du cancer au Canada: Ce qui est in, ce qui est out, ce qui sen vient
- Cancer screening in Canada: Whats in, whats out, whats coming
- The OncoSim-Breast cancer microsimulation model
- Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model
- Rapid recommendations: Updates from 2019 guidelines: part 1
- Lung Cancer Screening Guidelines Implementation in Primary Care: A Call to Action
- ESR/ERS statement paper on lung cancer screening
- The impact of perceived risk, screening eligibility and worry on preference for lung cancer screening: a cross-sectional survey
- The Value of Combination Analysis of Tumor Biomarkers for Early Differentiating Diagnosis of Lung Cancer and Pulmonary Tuberculosis
- Qualite du processus de depistage: Un facteur critique neglige et un element essentiel de la prise de decision partagee concernant le depistage
- Quality of the screening process: An overlooked critical factor and an essential component of shared decision making about screening
- Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort
- Organisation de la pratique pour le depistage preventif
- Practice organization for preventive screening
- Prise de decision partagee en soins de sante preventifs: Ce que cest; ce que ce nest pas
- Shared decision making in preventive health care: What it is; what it is not
- Prendre de meilleures decisions en matiere de depistage preventif: Equilibrer bienfaits et prejudices
- Better decision making in preventive health screening: Balancing benefits and harms
- Optimum low dose CT screening interval for lung cancer: the answer from NELSON?
More in this TOC Section
Similar Articles
Collections
Podcast